Sehrawat, R.; Pasrija, R.; Rathee, P.; Kumari, D.; Khatkar, A.; Küpeli Akkol, E.; Sobarzo-Sánchez, E.
Hybrid Caffeic Acid-Based DHFR Inhibitors as Novel Antimicrobial and Anticancer Agents. Antibiotics 2024, 13, 479.
https://doi.org/10.3390/antibiotics13060479
AMA Style
Sehrawat R, Pasrija R, Rathee P, Kumari D, Khatkar A, Küpeli Akkol E, Sobarzo-Sánchez E.
Hybrid Caffeic Acid-Based DHFR Inhibitors as Novel Antimicrobial and Anticancer Agents. Antibiotics. 2024; 13(6):479.
https://doi.org/10.3390/antibiotics13060479
Chicago/Turabian Style
Sehrawat, Renu, Ritu Pasrija, Priyanka Rathee, Deepika Kumari, Anurag Khatkar, Esra Küpeli Akkol, and Eduardo Sobarzo-Sánchez.
2024. "Hybrid Caffeic Acid-Based DHFR Inhibitors as Novel Antimicrobial and Anticancer Agents" Antibiotics 13, no. 6: 479.
https://doi.org/10.3390/antibiotics13060479
APA Style
Sehrawat, R., Pasrija, R., Rathee, P., Kumari, D., Khatkar, A., Küpeli Akkol, E., & Sobarzo-Sánchez, E.
(2024). Hybrid Caffeic Acid-Based DHFR Inhibitors as Novel Antimicrobial and Anticancer Agents. Antibiotics, 13(6), 479.
https://doi.org/10.3390/antibiotics13060479